Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival

Annals of Thoracic Surgery

Volumn 104, Issue 1, 2017, Pages 36-41

  Mehaffey, J Hunter ^a   Johnston, Lily E ^a   Hawkins, Robert B ^a   Charles, Eric J ^a   Yarboro, Leora ^a   Kern, John A ^a   Ailawadi, Gorav ^a   Kron, Irving L ^a   Ghanta, Ravi K ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FAMOTIDINE; METHYLENE BLUE; NITRIC OXIDE; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN; ENZYME INHIBITOR;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIOPULMONARY BYPASS; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART FUNCTION; HEART INDEX; HEART OUTPUT; HUMAN; KIDNEY FAILURE; LONG TERM SURVIVAL; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PRIORITY JOURNAL; REOPERATION; SIDE EFFECT; SIGNAL TRANSDUCTION; SURGICAL MORTALITY; SURGICAL PATIENT; VASODILATATION; VASOPLEGIA; WOUND INFECTION; ADVERSE EFFECTS; EPIDEMIOLOGY; HEART SURGERY; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS; VIRGINIA;

AGED; CARDIAC SURGICAL PROCEDURES; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; METHYLENE BLUE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; VASOPLEGIA; VIRGINIA;

EID: 85019554641     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2017.02.057     Document Type: Article

References (26)

1. Byrne, J.G., Leacche, M., Paul, S., et al. Risk factors and outcomes for 'vasoplegia syndrome' following cardiac transplantation. Eur J Cardiothorac Surg 25 (2004), 327–332.
2. Cremer, J., Martin, M., Redl, H., et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61 (1996), 1714–1720.
3. Fischer, G.W., Levin, M.A., Vasoplegia during cardiac surgery: current concepts and management. Semin Thorac Cardiovasc Surg 22 (2010), 140–144.
4. Levin, M.A., Lin, H.M., Castillo, J.G., Adams, D.H., Reich, D.L., Fischer, G.W., Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation 120 (2009), 1664–1671.
5. Mekontso-Dessap, A., Houel, R., Soustelle, C., Kirsch, M., Thebert, D., Loisance, D.Y., Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 71 (2001), 1428–1432.
6. Evora, P.R., Jose Rodrigues, A., Celotto, A.C., “Methylene blue should be relegated to rescue use and not as first-line therapy” cannot become a paradigm. J Cardiothorac Vasc Anesth 28 (2014), e11–e12.
7. Evora, P.R., Levin, R.L., Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass. J Thorac Cardiovasc Surg 127 (2004), 895–896 author reply 896.
8. Evora, P.R., Ribeiro, P.J., Vicente, W.V., et al. Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties. Rev Bras Cir Cardiovasc 24 (2009), 279–288.
9. Omar, S., Zedan, A., Nugent, K., Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment. Am J Med Sci 349 (2015), 80–88.
10. Weiner, M.M., Lin, H.M., Danforth, D., Rao, S., Hosseinian, L., Fischer, G.W., Methylene blue is associated with poor outcomes in vasoplegic shock. J Cardiothorac Vasc Anesth 27 (2013), 1233–1238.
11. Riha, H., Augoustides, J.G., Pro: methylene blue as a rescue therapy for vasoplegia after cardiac surgery. J Cardiothorac Vasc Anesth 25 (2011), 736–738.
12. Ozal, E., Kuralay, E., Yildirim, V., et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg 79 (2005), 1615–1619.
13. Maslow, A.D., Stearns, G., Butala, P., Schwartz, C.S., Gough, J., Singh, A.K., The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg 103 (2006), 2–8 table of contents.
14. Nantais, J., Dumbarton, T.C., Farah, N., et al. Impact of methylene blue in addition to norepinephrine on the intestinal microcirculation in experimental septic shock. Clin Hemorheol Microcirc 58 (2014), 97–105.
15. Werner, I., Guo, F., Bogert, N.V., et al. Methylene blue modulates transendothelial migration of peripheral blood cells. PLoS One, 8, 2013, e82214.
16. Menardi, A.C., Viaro, F., Vicente, W.V., Rodrigues, A.J., Evora, P.R., Hemodynamic and vascular endothelium function studies in healthy pigs after intravenous bolus infusion of methylene blue. Arq Bras Cardiol 87 (2006), 525–532.
17. Siriwardena, D.K., Tagori, H., Thiemermann, C., Nitric oxide synthase inhibitors. Methods Mol Med 36 (2000), 115–131.
18. Alfirevic, A., Xu, M., Johnston, D., Figueroa, P., Koch, C.G., Transfusion increases the risk for vasoplegia after cardiac operations. Ann Thorac Surg 92 (2011), 812–819.
19. Kortekaas, K.A., Lindeman, J.H., Versteegh, M.I., Stijnen, T., Dion, R.A., Klautz, R.J., Preexisting heart failure is an underestimated risk factor in cardiac surgery. Neth Heart J 20 (2012), 202–207.
20. Dagenais, F., Mathieu, P., Rescue therapy with methylene blue in systemic inflammatory response syndrome after cardiac surgery. Can J Cardiol 19 (2003), 167–169.
21. Leite, E.G., Ronald, A., Rodrigues, A.J., Evora, P.R.B., Is methylene blue of benefit in treating adult patients who develop catecholamine-resistant vasoplegic syndrome during cardiac surgery?. Interact Cardiovasc Thorac Surg 5 (2006), 774–778.
22. Colson, P.H., Bernard, C., Struck, J., Morgenthaler, N.G., Albat, B., Guillon, G., Post cardiac surgery vasoplegia is associated with high preoperative copeptin plasma concentration. Crit Care, 15, 2011, R255.
23. Raja, S.G., Fida, N., Should angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation?. Interact Cardiovasc Thorac Surg 7 (2008), 470–475.
24. Kortekaas, K.A., Lindeman, J.H., Reinders, M.E., et al. Pre-existing endothelial cell activation predicts vasoplegia after mitral valve surgery. Interact Cardiovasc Thorac Surg 17 (2013), 523–530.
25. Kofidis, T., Struber, M., Wilhelmi, M., et al. Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation. J Thorac Cardiovasc Surg 122 (2001), 823–824.
26. Michel, S., Weis, F., Sodian, R., et al. Use of methylene blue in the treatment of refractory vasodilatory shock after cardiac assist device implantation: report of four consecutive cases. J Clin Med Res 4 (2012), 212–215.